← Insider buys
KPTI

Karyopharm Therapeutics Inc. · Healthcare

EVP, Chief Dev. Officer Ran Frenkel sold $36K of Karyopharm Therapeutics Inc.

Sold$35,509
$12.12Price
2,929Shares
−3%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Thu, Feb 17. Filed Tue, Feb 22, 11:16 AM ET, during the session. Not investment advice.